Source: Annual Congress 2010 - Biomarkers for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Cherneva, O. Georgiev, D. Petrova, M. Stamenova, N. Trifonova (Sofia, Bulgaria). Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance. Eur Respir J 2010; 36: Suppl. 54, 3242

Member's Comments

No comment yet.

Related content which might interest you: Plasma levels of alpha crystalline antibodies in NSCLC patients – Diagnostic significance Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Prognostic significance of plasma D-dimer (DD) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 EGFR and hTERT expression in high risk COPD patients – clinical application Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 TTF-1 in advanced SCLC – Diagnostic and prognostic relevance Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002 The clinical significance of serum VEGF C, VEGF D and sVEGFR2 concentration in lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Clinical significance of hypoxia inducible factor-1α and VEGF expression in lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004 Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003 Differential regulation of TNF-α and TGF- β production by PAI-1 in lung cancer and endothelial cells Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Prognostic value of C-reactive protein and alpha 1 acid glycoprotein in pulmonary tuberculosis Source: Annual Congress 2003 - Epidemiology of tuberculosis in adults and children Year: 2003 α-b crystallin – a marker for inflammation in COPD patients Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 LSC - 2017 - The serum levels of alpha-1 antitrypsin are strongly associated with its local production by NSCLC tumor cells Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 High levels of serum cholesterol – protective and predictive factor for activation of tuberculosis; practical considerations Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Prognostic value of circulating MUC1/KL-6 with selectin ligands in patients with lung adenocarcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 481s Year: 2005